| Literature DB >> 29527501 |
Xiongying Chen1, Zhifang Zhang1, Qiumei Zhang2, Wan Zhao1, Jinguo Zhai3, Min Chen3, Boqi Du1, Xiaoxiang Deng1, Feng Ji3, Chuanyue Wang4, Yu-Tao Xiang5, Hongjie Wu6, Qi Dong1, Chuansheng Chen7, Jun Li8.
Abstract
ZNF804A rs1344706 (A/C) was the first SNP that reached genome-wide significance for schizophrenia. Recent studies have linked rs1344706 to functional connectivity among specific brain regions. However, no study thus far has examined the role of this SNP in the entire functional connectome. In this study, we used degree centrality to test the role of rs1344706 in the whole-brain voxel-wise functional connectome during the resting state. 52 schizophrenia patients and 128 healthy controls were included in the final analysis. In our whole-brain analysis, we found a significant interaction effect of genotype × diagnosis at the precuneus (PCU) (cluster size = 52 voxels, peak voxel MNI coordinates: x = 9, y = - 69, z = 63, F = 32.57, FWE corrected P < 0.001). When we subdivided the degree centrality network according to anatomical distance, the whole-brain analysis also found a significant interaction effect of genotype × diagnosis at the PCU with the same peak in the short-range degree centrality network (cluster size = 72 voxels, F = 37.29, FWE corrected P < 0.001). No significant result was found in the long-range degree centrality network. Our results elucidated the contribution of rs1344706 to functional connectivity within the brain network, and may have important implications for our understanding of this risk gene's role in functional dysconnectivity in schizophrenia.Entities:
Keywords: Brain network; Degree centrality; Functional magnetic resonance imaging; PCC/PCU; Schizophrenia; ZNF804A
Mesh:
Substances:
Year: 2017 PMID: 29527501 PMCID: PMC5842752 DOI: 10.1016/j.nicl.2017.12.017
Source DB: PubMed Journal: Neuroimage Clin ISSN: 2213-1582 Impact factor: 4.881
Demographics and clinical characteristics of the participants.
| SCZ | Healthy control | Total | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | ||||||||||
| AA | CA/CC | AA | CA/CC | AA | CA/CC | |||||||
| Age (years) | 27.44 ± 6.81 | 28.24 ± 8.78 | 0.11 | 0.74 | 26.84 ± 4.57 | 27.20 ± 6.11 | 0.91 | 0.76 | 27.06 ± 5.42 | 27.47 ± 6.88 | 0.14 | 0.71 |
| Gender (male/female) | 18 (15/3) | 34 (30/4) | 0.24 | 0.68 | 32 (25/7) | 96 (74/22) | 0.02 | 1.00 | 50 (40/10) | 130 (104/26) | 0.00 | 1.00 |
| Education (years) | 12.44 ± 2.85 | 13.00 ± 3.19 | 0.38 | 0.54 | 13.62 ± 2.64 | 12.59 ± 3.19 | 2.72 | 0.10 | 13.20 ± 2.75 | 12.70 ± 3.18 | 0.96 | 0.33 |
| PANSS positive score | 19.33 ± 11.12 | 17.91 ± 10.28 | 0.21 | 0.65 | NA | NA | NA | NA | NA | NA | NA | NA |
| PANSS negative score | 16.28 ± 10.49 | 17.62 ± 9.96 | 0.21 | 0.65 | NA | NA | NA | NA | NA | NA | NA | NA |
| PANSS total score | 62.89 ± 38.88 | 68.35 ± 33.99 | 0.28 | 0.60 | NA | NA | NA | NA | NA | NA | NA | NA |
| Number of episodes | 2.72 ± 1.56 | 2.85 ± 1.51 | 0.09 | 0.76 | NA | NA | NA | NA | NA | NA | NA | NA |
| Age of onset (years) | 20.88 ± 3.99 | 21.74 ± 4.48 | 0.46 | 0.49 | NA | NA | NA | NA | NA | NA | NA | NA |
| Illness duration (months) | 72.66 ± 59.14 | 70.28 ± 71.29 | 0.02 | 0.90 | NA | NA | NA | NA | NA | NA | NA | NA |
| Medication dosage (mg/day) | 310.72 ± 273.52 | 224.88 ± 172.53 | 1.92 | 0.17 | NA | NA | NA | NA | NA | NA | NA | NA |
Chlorpromazine equivalents.
Fig. 1Full factorial ANOVA across the whole-brain whole-range degree centrality network showed a significant interaction effect of genotype × diagnosis at the PCU (Panel A, the maximal peak voxel MNI coordinates: x, y, z = [9–69 63]). Further analysis found that the interaction effect was limited to short-range connections (Panel C). Separate analyses for patients and controls found that these effects were specific to patients (Panel B for whole-range, Panel D for short-range).